# Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting

> **NCT02786576** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 236 (actual)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02786576
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-05
- **Primary completion:** 2019-01-07
- **Final completion:** 2019-01-07
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2020-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02786576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02786576, "Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02786576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*